Ameish Govindarajan

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza et al. · Nature Medicine · 2024 · 64 citations · Full text

Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.

Hedyeh Ebrahimi, Luís Meza, Keehoon Lee et al. · Journal of Clinical Oncology · 2023 · 20 citations

Randomized Clinical Trial, Immunodeficiencies, Immunology +22

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma

Nazlı Dizman, Ameish Govindarajan, Zeynep Büşra Zengin et al. · Clinical Genitourinary Cancer · 2023 · 18 citations

Urology, Cancer Immunosurveillance, Genitourinary Cancer +7

Integrative Oncology and the Clinical Care Network: Challenges and Opportunities

G. Semeniuk, Bahareh Bahadini, Eugene R. Ahn et al. · Journal of Clinical Medicine · 2023 · 15 citations · Full text